Primary pulmonary NFATC2::NUTM2-associated myoepithelial-like neoplasms: two hi-C-detected cases beyond routine targeted NGS and review of the literature [0.03%]
原发性肺NFATC2::NUTM2融合相关肌上皮样肿瘤:两例基于Hi-C技术发现的病例及文献复习
Jiayu Li,Ting Lan,Min Shi et al.
Jiayu Li et al.
Rearrangements involving NFATC2 define a heterogeneous group of neoplasms, and NFATC2::NUTM2-associated tumors of the lung and salivary glands have recently emerged as a distinctive clinicopathologic entity. We report two primary pulmonary ...
ASPSCR1::TFE3-rearranged renal cell carcinomas: clinicopathologic, molecular, and survival analysis of 30 cases [0.03%]
ASPS-CRC1型TFE3重排肾细胞癌的临床病理、分子和生存分析(30例报告)
Ying Yang,Zhengzheng Su,Mengxin Zhang et al.
Ying Yang et al.
ASPSCR1::TFE3-rearranged renal cell carcinoma (RCC) represents the most common subtype of TFE3-rearranged RCC, yet clinicopathologic and prognostic data remain limited. We analyzed 30 cases confirmed by fluorescence in situ hybridization or...
MYD88L265P mutation is a highly specific marker for the nonGCB/ABC DLBCL molecular subtype [0.03%]
MYD88L265P突变是非生发中心G2期(BNGB/ABC)DLBCL分子亚型的高特异性标志
Lucia Sánchez Magdaleno,Aitana Avendaño Pomares,Patricia Arribas et al.
Lucia Sánchez Magdaleno et al.
Mutations in the innate immune adapter MYD88 occur selectively in Lymphoplasmacytic lymphoma (LPL) of the IgM/WM subtype and ABC type DLBCL. We used MYD88L265P mutation detection based on AS-PCR using genomic DNA extracted from FFPE tissue ...
Analysis of pathological diagnostic characteristics of non-esophageal eosinophilic gastrointestinal disorders [0.03%]
非食管嗜酸性胃肠疾病的病理诊断特征分析
Li Xiaoyu,Mao Xinxin,Li Kaiwen et al.
Li Xiaoyu et al.
To investigate the pathological diagnostic features of non-esophageal eosinophilic gastrointestinal disorders (non-EoE EGIDs) and establish site-specific pathological diagnostic workflows. A retrospective case-control study was conducted on...
Fibrotic marrow limiting morphologic classification in MDS/MPN with SF3B1 mutation and thrombocytosis: diagnostic implications under the ICC 2022 framework [0.03%]
基于ICC 2022框架下SF3B1突变及血小板增多的MDS/MPN中骨髓纤维化限制了形态学分类:诊断意义
Ozgur Can Eren,Raajit Rampal,Mikhail Roshal et al.
Ozgur Can Eren et al.
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis (MDS/MPN-SF3B1-T) is a genetically defined overlap entity integrating morphologic and molecular features. Assessment of ring sideroblasts may be unreliable i...
Evidence from intra-patient progression indicates adenoid ameloblastoma as a phenotypic variant of dentinogenic ghost cell tumor [0.03%]
来自同一患者的肿瘤演变证据表明成牙本质 ghost 细胞瘤是腺样成釉细胞瘤的表型变异体
Mengxin Ren,Yanan Sun,Shaodong Yang et al.
Mengxin Ren et al.
Adenoid ameloblastoma (AA) and dentinogenic ghost cell tumor (DGCT) show marked morphologic and molecular overlap but remain classified as distinct odontogenic entities largely on the basis of architectural predominance. We studied 3 patien...
Granulomatous prostatitis as a cause of elevated PI-RADS scores on multiparametric MRI: insights from a single institution cohort [0.03%]
基于单一机构队列的多参数MRI高PI-RADS评分的原因之一:肉芽肿性前列腺炎的影像学表现分析
Robert G Colef,Adam T Froemming,Naoki Takahashi et al.
Robert G Colef et al.
Granulomatous prostatitis (GP) frequently mimics prostatic adenocarcinoma on multiparametric MRI (mpMRI), producing elevated PI-RADS scores and diagnostic challenges. We retrospectively analyzed 63 patients with biopsy-proven GP (without co...
Clinicopathologic spectrum and diagnostic strategies of intrahepatic neoplasms with prominent inflammatory background [0.03%]
具有显著炎症背景的肝内肿瘤的临床病理谱和诊断策略
Haifeng Li,Na Cheng,Donglin Tan et al.
Haifeng Li et al.
Intrahepatic neoplastic lesions with prominent inflammatory background (HNLwPIBs) constitute a heterogeneous group of entities that frequently pose substantial diagnostic challenges because of overlapping morphological features. To characte...
Correction to: Renal cell carcinoma with a novel RAB1A::ALK fusion: expanding the molecular spectrum of ALK-rearranged RCC [0.03%]
纠正:具有新颖的RAB1A::ALK融合的肾细胞癌:扩大了重排的RCC分子谱系中的ALK范围
Claudia Andrea Gómez González,Banu Sarsik Kumbaraci,Fuat Kizilay et al.
Claudia Andrea Gómez González et al.
Reply to Varma et al. regarding building consensus in medicine: issues and potential solutions [0.03%]
关于医学界形成共识的问题及潜在解决方案的回复
Brett Delahunt,Hemamali Samaratunga,David Bostwick et al.
Brett Delahunt et al.